News & Analysis on Clinical Trial Services & Contract Research And Development
Applied Biosystems Group reported a 40 per cent leap in profits as the company released its forth quarter 2005 figures. The rise in sales reflects the increased demand for biosecurity and human identification products as well as its TaqMan gene...
Cara Therapeutics has announced positive results of a phase 1 clinical trial for its new class of peripherally acting kappa opioid agonists currently under development for the treatment of postoperative pain.
MAP Pharmaceuticals has broadened its agreement with Elan Corp to develop improved formulations of respiratory drugs to include combination asthma treatments and inhaled drugs for other lung diseases.
A new device - dubbed an "optoelectronic tweezer," enables researchers to manipulate large numbers of single cells and particles using optical images projected onto a glass slide coated with photoconductive materials. The device could prove essential...
Invitrogen Corporation has acquired the publicly held life sciences company BioSource International in a transaction totalling approximately $130 million. This deal adds to Invitrogen's growing collection of protein and primary antibody products...